<DOC>
	<DOC>NCT00554385</DOC>
	<brief_summary>The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.</brief_summary>
	<brief_title>A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>The subject was randomized into Base Study (M06888 or M10345) and completed the Treatment Period. If female, subject must be practicing at least one method of birth control throughout the study. If female, the result of a pregnancy test is negative. The subject is judged to be in generally good health. The subject experienced a serious adverse event in Base Study (M06888 or M10345) that the investigator considered "possibly" or "probably related" to study drug. The subject has taken any ADHD medication between the last dose of study drug in Study M06888 or M10345 and the first dose of study drug in the current study. The subject has a positive urine drug screen for alcohol or drugs of abuse. The subject anticipates a move outside the geographic area.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>